Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StrataXRT vs Aquaphor for Radiation Dermatitis
NCT05553392Terminated
- Sponsor
- Stratpharma
- Start
- Nov 2022
- Primary completion
- May 2024
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Stratpharma. Primary endpoint: Incidence of acute >grade 2 radiation dermatitis. Started Nov 2022; status: terminated.
Beyond the preview
Go deeper on NCT05553392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05553392.